- Home
- SXTP vs YCBD Comparison
SXTP vs YCBD Comparison
Compare SXTP & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- YCBD
- Stock Information
- Founded
- SXTP 2010
- YCBD 2015
- Country
- SXTP United States
- YCBD United States
- Employees
- SXTP N/A
- YCBD N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- SXTP Health Care
- YCBD Health Care
- Exchange
- SXTP Nasdaq
- YCBD Nasdaq
- Market Cap
- SXTP 6.7M
- YCBD 7.8M
- IPO Year
- SXTP 2023
- YCBD N/A
- Fundamental
- Price
- SXTP $1.38
- YCBD $0.88
- Analyst Decision
- SXTP Buy
- YCBD Strong Buy
- Analyst Count
- SXTP 2
- YCBD 1
- Target Price
- SXTP $3.00
- YCBD $2.00
- AVG Volume (30 Days)
- SXTP 287.4K
- YCBD 608.2K
- Earning Date
- SXTP 11-14-2025
- YCBD 12-17-2025
- Dividend Yield
- SXTP N/A
- YCBD N/A
- EPS Growth
- SXTP N/A
- YCBD N/A
- EPS
- SXTP N/A
- YCBD N/A
- Revenue
- SXTP $984,494.00
- YCBD $19,026,064.00
- Revenue This Year
- SXTP $81.41
- YCBD $0.37
- Revenue Next Year
- SXTP $83.17
- YCBD $4.95
- P/E Ratio
- SXTP N/A
- YCBD N/A
- Revenue Growth
- SXTP 128.70
- YCBD N/A
- 52 Week Low
- SXTP $1.22
- YCBD $0.59
- 52 Week High
- SXTP $12.45
- YCBD $6.54
- Technical
- Relative Strength Index (RSI)
- SXTP 42.79
- YCBD 40.93
- Support Level
- SXTP $1.43
- YCBD $0.94
- Resistance Level
- SXTP $1.52
- YCBD $1.09
- Average True Range (ATR)
- SXTP 0.11
- YCBD 0.13
- MACD
- SXTP -0.02
- YCBD -0.05
- Stochastic Oscillator
- SXTP 6.12
- YCBD 5.27
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.